Detalles de la búsqueda
1.
Risk of Subsequent Events in Patients With Minor Ischemic Stroke or High-Risk Transient Ischemic Attack.
J Korean Med Sci
; 37(33): e254, 2022 Aug 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35996931
2.
Cost-effectiveness of dapagliflozin as an adjunct to insulin for the treatment of type 1 diabetes mellitus in the United Kingdom.
Diabetes Obes Metab
; 22(7): 1047-1055, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32037675
3.
Relationship between hypoglycaemia, body mass index and quality of life among patients with type 1 diabetes: Observations from the DEPICT clinical trial programme.
Diabetes Obes Metab
; 22(5): 857-865, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31970881
4.
Systematic literature review and network meta-analysis of sodium-glucose co-transporter inhibitors vs metformin as add-on to insulin in type 1 diabetes.
Diabetes Obes Metab
; 22(1): 39-50, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31468649
5.
Disease Burden Following Non-Cardioembolic Minor Ischemic Stroke or High-Risk TIA: A GWTG-Stroke Study.
J Stroke Cerebrovasc Dis
; 29(12): 105399, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33254370
6.
Cost-effectiveness of ticagrelor plus aspirin versus aspirin in acute ischaemic stroke or transient ischaemic attack: an economic evaluation of the THALES trial.
BMJ Neurol Open
; 5(2): e000478, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37637218
7.
Cost-effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease: a European economic evaluation of the THEMIS trial.
Eur Heart J Cardiovasc Pharmacother
; 8(8): 777-785, 2022 12 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35488865
8.
Adverse Changes in HbA1c, Body Weight and Insulin Use in People with Type 1 Diabetes Mellitus Following Dapagliflozin Discontinuation in the DEPICT Clinical Trial Programme.
Diabetes Ther
; 11(5): 1135-1146, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32274678
Resultados
1 -
8
de 8
1
Próxima >
>>